• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Newsletters » The Carlat Child Psychiatry Report
carlat-child-header.png

The Carlat Child Psychiatry Report

Autism in Children and Adolescents (April/May/June) | 2021

View Archived Issues

Welcome to the 21st Century Cures Act Information Sharing Rules

May 20, 2021
Jess Levy, MD.
Clinicians need to efficiently respond to patient requests for records and document their considered judgment in decisions about restricting records to patients and families. Read More

Learning Objectives, Autism in Children and Adolescents, CCPR, April/May/June 2021

May 20, 2021
After reading these articles, you should be able to… Read More

ECT in Severe Adolescent Mood ­Disorders

May 20, 2021
John Raiss, MD.
Electroconvulsive therapy (ECT) remains both controversial and difficult to obtain for children and adolescents. Yet when our young patients have truly severe and life-threatening neuropsychiatric conditions, when medication is not going to cut it, we look to ECT for possible help. This research review offers guidance for use of ECT. Read More

The Effect of Age and Pubertal Stage on Mental Health in Gender-Incongruent Youths

May 20, 2021
John Raiss, MD.
When is the best time to begin gender affirming medical care (GAMC) with respect to addressing the mental health status of children and adolescents with Gender Dysphoric Disorder? Should we begin Hormone Replacement Therapy early or wait until the adolescent is older? This research update will help you grapple with this very public debate. Read More

Note From the Editor-in-Chief

May 20, 2021
Joshua Feder, MD
At Carlat we dig deeper: Last fall it was the possibility of suicidality with antidepressants when we see the real data; this winter, it was the lack of clinical relevance of CYP enzyme testing when we use medications carefully; and this spring, beneath the apparent weight of thousands of studies that turn out to be flawed, we found an absence of a definable effect size for the massive $17 billion applied behavioral analysis industry. Read More

Approaches to Autism Intervention

May 20, 2021
Diane Cullinane, MD.
How to respond to the seismic shift in our understanding of effect sizes in autism treatment? With better informed consent: we supplemented our interview with Dr Sandbank with an article by Dr Diane Cullinane on the three main kinds of autism treatment so that you will be prepared to help families know that they have choices. Read More

Effect Size Matters: The Seismic Shift Toward Naturalistic and Developmental Interventions in Autism

May 20, 2021
Micheal P Sandbank, PhD
Thousands of studies that carry the weight of support for Applied Behavioral Analysis treatment for autism are flawed. See what we learned about effect sizes for this massive 17-billion-dollar industry and learn about why it is so hard to study more functional but meaningful change vs rote but less useful learning. Read More

Viloxazine (Qelbree): A Faster Strattera?

May 20, 2021
Joshua Feder, MD, and Talia Puzantian, PharmD, BCPP.
As of April, 2021, we have a brand new non-stimulant medication approved for treatment of ADHD in the US. Are we excited? Does this represent an advance over other efforts to produce effective non-stimulant medications for ADHD, or is it another instance of ‘me too’? What does the supporting research tell us? And what side effects do we need to watch out for? Read and learn. Read More

Pharmacotherapy for Autism Spectrum Disorder

May 20, 2021
Matthew Krause, DO
What’s new in psychopharmacological treatment for autism? We interviewed Dr. Matthew Krause on his recent review of seven studies covering the rationale for treatment, target symptoms, the use of antipsychotics, over the counter supplements, and some new ideas in pharmacotherapy for ASD. Read More

CME Post-Test - Autism in Children and Adolescents, CCPR, April/May/June 2021

May 20, 2021
By successfully completing the test you will be awarded a certificate for 2 CME credits. Read More
SUBSCRIBE NOW
DOWNLOAD NOW
Editor-in-Chief
JFeder1.png
Joshua Feder, MD

Dr. Joshua Feder studied mathematics and medicine at Boston University, Psychiatry at Naval Regional Medical Center San Diego, serving the first Gulf War in child and adolescent psychiatry fellowship at Tripler Army Medical Center in Honolulu, and eventually became Chief of Child Psychiatry at the National Naval Medical Center in Bethesda, MD. Dr. Feder now practices in Solana Beach, California, and serves as Executive Medical Director at Positive Development, providing relationship-based support for families, with research at UCSD, SDSU, Fielding Graduate University, An Najah National University, Quicksilver Software, Autism Is inclusion program, and Programmatic Lead for the International Networking Group on Peace Building with Young Children, with projects in the US, Northern Ireland, and the Middle East. Dr. Feder co-authored the first American Academy of Child & Adolescent Psychiatry Practice Parameter on Autism and serves as Co-Chair of the Disaster & Trauma Committee at AACAP. Dr Feder was founding policy chair for the California Association for Infant Mental Health and advocates worldwide on access to care, climate policy, and peacebuilding. His recent books include Child Medication Fact Book for Psychiatric Practice, Second Edition (2023) and Prescribing Psychotropics (2021).

Full Editorial Information
Featured Book
  • PB4e_Cover2.png

    Psychiatry Practice Boosters, Fourth Edition (2023)

    Teaches you the key points of 63 of the most clinically relevant studies in psychiatry.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2622607431.jpg
    General Psychiatry

    Should You Test MTHFR?

    MTHFR is a...
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.